IL1B and COVID-19: Previous data could show that the major pro‐inflammatory cytokine Interleukin‐1‐beta (IL‐1β) is elevated in plasma from hospitalized COVID‐19 patients and its associated signaling pathway seems to drive SARS‐CoV‐2 pathogenicity (Cavalli et al, 2020; Huet et al, 2020; Rodrigues et al, 2021).